Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Duloxetine effects on pain perception and C-fiber function in major depression
2006-006957-29Phase 3Completed
- Sponsor
- Klinik für Psychiatrie und Psychotherapie, Universitätsklinikum Jena
- Start
- Apr 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of duloxetine in major depressive disorder (MDD) (2 arms), sponsored by Klinik für Psychiatrie und Psychotherapie, Universitätsklinikum Jena. Primary endpoints: Improvement of A-delta and C-fiber stimulation reaction in major depressive disorder, Electrical pain thresholds and tolerances and 3 more. Started Apr 2007; status: completed.
02
Drugs
duloxetine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on 2006-006957-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-006957-29.